This inventor holds 2 USPTO granted patents, plus 2 CIPO patents. Top assignee: Molnlycke Health Care Ab. Active years: 2012-2018.
Company Filing History:
Years Active: 2012-2018
Title: Malin Prydz: Innovator in Hydrophilic Polyurethane Foam Structures
Introduction
Malin Prydz is a notable inventor based in Stora Hoga, Sweden. She has made significant contributions to the field of hydrophilic polyurethane foam structures, holding 2 patents that showcase her innovative methods and applications.
Latest Patents
Her latest patents include a "Particle-containing foam structure" and a "Silver-containing foam structure." The particle-containing foam structure patent describes a method for producing a hydrophilic polyurethane foam that incorporates inert activated carbon particles. This process involves creating a water phase with a surfactant and dispersed particles, mixing it with an isocyanate-terminated polyether, and then transferring the mixture to a mold to form the foam structure. The final product is dried to achieve a moisture content of no more than 10%. Additionally, the silver-containing foam structure patent outlines a similar method but focuses on incorporating various silver salts into the foam. This innovative approach also results in a hydrophilic polyurethane foam structure suitable for wound dressings.
Career Highlights
Malin Prydz is currently employed at Mölnlycke Health Care AB, where she continues to develop her expertise in medical innovations. Her work has significantly impacted the healthcare industry, particularly in the development of advanced wound care products.
Collaborations
Throughout her career, Malin has collaborated with notable colleagues, including Stefan Areskoug and Magnus Nolmark. These partnerships have fostered a creative environment that encourages innovation and the advancement of healthcare solutions.
Conclusion
Malin Prydz is a pioneering inventor whose work in hydrophilic polyurethane foam structures has led to significant advancements in medical technology. Her contributions continue to influence the field and improve patient care.